Literature DB >> 12967871

Amniotic membrane transplantation to reconstruct the conjunctival surface in cases of chemical burn.

Yasemin A Katircioglu1, Koray Budak, Sibel Salvarli, Sunay Duman.   

Abstract

PURPOSE: To evaluate the efficiency of preserved human amniotic membrane transplantation for conjunctival surface reconstruction in cases of chemical burn.
METHODS: Preserved amniotic membrane transplantation was performed in 6 patients (6 eyes) having symblepharon and fornix insufficiency due to chemical burn. Amniotic membrane was sutured to the intact conjunctiva after the fibrotic tissue was excised. The fornix was reconstructed in cases having fornix insufficiency. These cases were followed up for 4-24 months.
RESULTS: During the mean follow-up period (10+/-7.37 months) adequate bulbar conjunctiva and fornix depth was achieved in 5 patients without recurrence and with mild fibrosis. In 1 patient who did not have a healthy conjunctiva preoperatively, conjunctival fibrosis and symblepharon recurred.
CONCLUSIONS: Preserved human amniotic membrane transplantation is a good alternative treatment method for conjunctival surface reconstruction in those cases with some healthy peripheral conjunctival tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967871     DOI: 10.1016/s0021-5155(03)00109-6

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  3 in total

1.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

2.  Issues of rehabilitation of the patients with symblepharon using oral mucosal autografts.

Authors:  Marina B Gushchina; Alexander V Gushchin; Daria S Afanasyeva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-10-19       Impact factor: 3.117

3.  A rabbit model for assessing symblepharon after alkali burn of the superior conjunctival sac.

Authors:  Yanwei Kang; Shaowei Li; Chang Liu; Mintian Liu; Shuai Shi; Man Xu; Jingliang He; Tao Zhang
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.